PubMed Summary

Title Average Ratingsort ascending
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis. 100.00%
Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma. 100.00%
Active specific immunotherapy with supportive measures in the treatment of palliatively nephrectomized, renal adenocarcinoma pat 100.00%
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression 100.00%
The need for ibogaine in drug and alcohol addiction treatment. 100.00%
Ukrain (NSC-631570) in the treatment of pancreas cancer. 95.00%
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. 95.00%
Biophotonics in the infrared spectral range reveal acupuncture meridian structure of the body. 95.00%
Low-dose naltrexone for disease prevention and quality of life. 95.00%
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. 95.00%
Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study. 95.00%
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. 95.00%
Adaptive therapy. 90.00%
In-vitro toxicity of Ukrain against human Ewing tumor cell lines. 90.00%
Low-dose naltrexone therapy improves active Crohn's disease. 90.00%
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a 90.00%
Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer. 90.00%
The present state of antineoplaston research (1) 90.00%
Hibiscus sabdariffa L. Tea (Tisane) Lowers Blood Pressure in Prehypertensive and Mildly Hypertensive Adults 90.00%
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell 90.00%
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer. 90.00%
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. 90.00%
Low-dose naltrexone for the treatment of irritable bowel syndrome: a pilot study. 90.00%
A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. 90.00%
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic ca 90.00%
The use of mushroom glucans and proteoglycans in cancer treatment. 90.00%
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alp 90.00%
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ 90.00%
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. 90.00%
Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer. 90.00%
The Biofield Hypothesis: Its Biophysical Basis and Role in Medicine 90.00%
Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of the AMPA receptor. 90.00%
Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice 90.00%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. 90.00%
Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potent 90.00%
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial. 90.00%
Metabolic modulation of glioblastoma with dichloroacetate. 90.00%
Treatment of advanced pancreatic cancer with opioid growth factor: phase I. 90.00%
Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic soli 90.00%
Medicinal plants and cancer chemoprevention. 90.00%
Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure 90.00%
Is it time to test metformin in breast cancer clinical trials? 90.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). 90.00%
A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone mela 90.00%
Artesunate in the treatment of metastatic uveal melanoma--first experiences. 90.00%
The near-death experience: a cerebellar method to protect body and soul-lessons from the Iboga healing ceremony in Gabon. 90.00%
Immunomodulatory effects of opioids. 90.00%
Mistletoe therapy in oncology 90.00%
Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices 90.00%
Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's .... 90.00%
Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. 90.00%
Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? .. 90.00%
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. 90.00%
Chemotherapy of advanced epithelial cancer--a critical review 90.00%
Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. 90.00%
Hyperthermia adds to chemotherapy. 90.00%
Pomegranate juice: a heart-healthy fruit juice. 90.00%
Vitamin D for cancer prevention: global perspective. 90.00%
Efficacy of homeopathic therapy in cancer treatment 90.00%
The anti-angiogenic basis of metronomic chemotherapy. 85.00%
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. 85.00%
The ibogaine medical subculture. 85.00%
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial 85.00%
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. 80.00%
A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort 80.00%
Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour ce 80.00%
Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain 80.00%
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma 80.00%
Ukrain therapy of recurrent breast cancer with lung metastases (case report) 80.00%
Opiates and infection. 80.00%
Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy 80.00%
High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomised study. 80.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative.. 80.00%
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a .. 80.00%
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refract 80.00%
Clinical applications of magnetic nanoparticles for hyperthermia. 80.00%
Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression. 80.00%
Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled 80.00%
The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 ... 80.00%
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. 80.00%
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. 80.00%
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer 80.00%
Anthroposophic health care--different and home-like. 80.00%
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. 80.00%
A new prostaglandin disturbance syndrome in schizophrenia: delta-6-pyroluria. 80.00%
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high... 80.00%
Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patient 80.00%
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. 80.00%
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. 80.00%
Effect of some isoquinoline alkaloids on enzymatic activity of acetylcholinesterase and monoamine oxidase 80.00%
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate ca 80.00%
Ukrain monotherapy in malignant melanoma (case report) 80.00%
Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell c 80.00%
Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in--- 80.00%
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. 80.00%
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expressio 80.00%
Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside. 80.00%
N-acetylcysteine inhibits proliferation, adhesion, migration and invasion of human bladder cancer cells. 80.00%
Low-Dose Naltrexone Therapy Improves Active Crohn’s Disease 80.00%

Pages